Stay updated on Opregen in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedUpdated the study record’s metadata dates (e.g., last update posted/submitted and related verification) and the ClinicalTrials.gov page revision/version number, reflecting a non-content update to the record.SummaryDifference0.3%

- Check19 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedNew update entries dated 2026-03-23, 2026-03-20, and 2026-03 were added. Older update entries dated 2026-03-02, 2026-02-27, and 2026-02 were removed.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; it appears to be a backend/systems update with no visible changes to study details or navigation.SummaryDifference0.1%

- Check55 days agoChange DetectedFooter Revision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

- Check62 days agoChange DetectedDuke Eye Center in Durham, NC was added to the study locations, bringing the total sites to 17 and the recruitment status to Recruiting.SummaryDifference0.5%

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.